Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups (2023)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.47626/1516-4446-2023-3377
- Subjects: ANTICONVULSIVANTES; CANNABIS; CONVULSÕES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Psychiatry
- ISSN: 1516-4446
- Volume/Número/Paginação/Ano: v. 45, n. 6, p. 463-464, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ZUARDI, Antônio Waldo e CRIPPA, José Alexandre de Souza. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.47626/1516-4446-2023-3377. Acesso em: 19 fev. 2026. , 2023 -
APA
Zuardi, A. W., & Crippa, J. A. de S. (2023). Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.47626/1516-4446-2023-3377 -
NLM
Zuardi AW, Crippa JA de S. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 6): 463-464.[citado 2026 fev. 19 ] Available from: https://doi.org/10.47626/1516-4446-2023-3377 -
Vancouver
Zuardi AW, Crippa JA de S. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 6): 463-464.[citado 2026 fev. 19 ] Available from: https://doi.org/10.47626/1516-4446-2023-3377 - Induction of psychosis by Δ9- Tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience precessing
- Cannabis affects people differently: inter-subject variation in the psychotogenic effects of ''delta' POT.9'-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers
- A conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans
- Cannabidiol is a potential therapeutic for the affective-motivational dimension of incision pain in rats
- Uso de maconha e ansiedade
- Distinct effects of 'delta'9-Tetrahydrocannabinol and cannabidiol on neural activation during emotional processing
- Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers
- Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
- Modulation of effective connectivity during emotional processing by ''DELTA' POT.9'-tetrahydrocannabinol and cannabidiol
- Duloxetine in the treatment of panic disorder
Informações sobre o DOI: 10.47626/1516-4446-2023-3377 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003199427.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
